Earnings History Data for Phathom Pharmaceuticals, Inc. (PHAT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel treatments for gastrointestinal diseases. The company's product pipeline consists of vonoprazan, which are in clinical stage. Phathom Pharmaceuticals Inc. is based in Buffalo Grove, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-03-2024 | PM | PHAT | Phathom Pharmaceuticals, Inc. | 568.52 | -0.80 | -0.92 | -1.33 | Phathom Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.20, revenue of $0.68M beats by $0.3M [3/7/2024 8:04 AM] |
9.09 | -0.64 (-6.63%) |
10.50 | 0.77 (7.91%) |
5.84 - 17.02 | 1,237,123 | 1,030,000 | 4,849 | ||
| 09-11-2023 | PM | PHAT | Phathom Pharmaceuticals | 461.00 | -0.76 | -0.95 | 0.00 | Phathom Pharmaceuticals GAAP EPS of -$0.76 beats by $0.14 [11/9/2023 9:07 AM] |
7.87 | 0.05 (0.64%) |
8.18 | 0.36 (4.60%) |
5.84 - 17.02 | 626,939 | 720,000 | 522 | ||
| 10-08-2023 | PM | PHAT | Phathom Pharmaceuticals | 642.00 | -0.84 | -0.95 | 0.00 | Phathom Pharmaceuticals GAAP EPS of -$0.84 beats by $0.14 [8/10/2023 12:23 PM] |
15.72 | 0.59 (3.93%) |
15.57 | 0.44 (2.91%) |
5.84 - 16.14 | 957,042 | 320,000 | 219 | ||
| 01-03-2022 | AH | After the close (Mar 1) |
PHAT | Phathom Pharmaceuticals | 581.00 | -0.95 | -0.86 | 0.00 | Phathom Pharmaceuticals GAAP EPS of -$0.95 beats by $0.05 [3/1/2022 5:04 PM] |
18.50 | 0.37 (2.04%) |
17.50 | -0.63 (-3.47%) |
14.04 - 50.78 | 83,430 | 110,000 | 1,200 | |
| 08-11-2021 | PM | PHAT | Phathom Pharmaceuticals | 747.00 | -0.98 | -0.78 | 0.00 | Phathom Pharmaceuticals reports Q3 results [11/8/2021 8:49 AM] |
22.60 | 0.26 (1.16%) |
22.34 | 0.0 (0.00%) |
21.71 - 50.78 | 176,337 | 230,000 | 8,365 | ||
| 10-08-2021 | PM | PHAT | Phathom Pharmaceuticals, Inc. | 1,056 | -1.00 | -1.07 | 0.00 | Phathom Pharmaceuticals EPS beats by $0.08 [8/10/2021 8:53 AM] |
32.96 | 0.92 (2.87%) |
0.0 | 0.0 (0.00%) |
30.46 - 50.78 | 221,514 | 80,000 | 0 | ||
| 11-05-2021 | PM | PHAT | Phathom Pharmaceuticals, Inc. | 996.92 | -0.96 | -1.11 | -0.62 | Phathom Pharmaceuticals EPS beats by $0.24 [5/11/2021 8:53 AM] |
34.09 | 1.12 (3.40%) |
0.0 | 0.0 (0.00%) |
28.10 - 64.54 | 82,510 | 120,000 | 0 | ||
| 30-03-2021 | AH | PHAT | Phathom Pharmaceuticals, Inc. | 1,020 | -1.58 | -0.93 | 0.00 | Phathom Pharmaceuticals EPS misses by $0.56 [3/30/2021 5:00 PM] |
0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | ||
|
|
||||||||||||||||||
| 10-11-2020 | AH | PHAT | Phathom Pharmaceuticals, Inc. | 1,209 | -1.02 | -0.68 | 0.00 | Phathom Pharmaceuticals EPS misses by $0.35 [11/10/2020 4:47 PM] |
37.72 | -3.77 (-9.09%) |
41.49 | 0.0 (0.00%) |
18.51 - 64.54 | 45,761 | 70,941 | 233 | ||
|
|
||||||||||||||||||